Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06157333
Status:
COMPLETED
Last Update Posted:
2023-12-05
First Post:
2023-11-24
Brief Title:
Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation on Patients With Post-stroke Depression
Sponsor:
Ankara City Hospital Bilkent
Organization:
Ankara City Hospital Bilkent
Study Overview
Official Title:
Effect of Accelerated Repetitive Transcranial Magnetic Stimulation on Depression Symptoms in Patients With Subacute Ischemic Stroke
Status:
COMPLETED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The FDA approved repetitive transcranial magnetic stimulation rTMS for patients with Major Depressive Disorder MDD in 2008 The conventional rTMS protocol that has been used effectively for major depression is 5 days per week for 4-6 weeks The accelerated rTMS protocol involves conducting more than one session per day In the treatment of post-stroke depression PSD although the effectiveness of conventional rTMS procedure has been shown in many studies there is limited data on accelerated rTMS protocol in which the number of daily sessions is increased In this study we aimed to evaluate the efficacy of accelerated rTMS treatment on depression symptoms in patients diagnosed with PSD and whose depressive symptoms persist despite medical treatment by comparing it with sham stimulation
Question 1 Is accelerated rTMS an effective and reliable method in the treatment of post-stroke depression Question 2 Is accelerated rTMS effective on quality of life functional assessment and motor recovery in patients with post-stroke depression
Question 1 Is accelerated rTMS an effective and reliable method in the treatment of post-stroke depression Question 2 Is accelerated rTMS effective on quality of life functional assessment and motor recovery in patients with post-stroke depression
Detailed Description:
Objective Depression is a complication that negatively affects the quality of life and functional recovery of stroke patients and is associated with increased physical disability cognitive and social impairment In addition to being resistant to pharmacotherapy the side-effect profile of the drugs used in the treatment and the increase in stroke recurrence increase the need for new alternatives in the treatment of post-stroke depression PSD Repetitive transcranial magnetic stimulation rTMS is one of the treatment of interest in this field In the treatment of PSD although the effectiveness of conventional rTMS procedure has been shown in many studies there is limited data on accelerated rTMS protocol in which the number of daily sessions is increased In this study we aimed to evaluate the efficacy of accelerated rTMS treatment on depression symptoms in patients diagnosed with PSD and whose depressive symptoms persist despite medical treatment by comparing it with sham stimulation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None